CONMED CNMD Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Product | ||||||
| General Surgery | $786.54M+2.3% | $800.13M+4.9% | $791.25M+6.0% | $777.68M+5.0% | $768.63M+6.1% | |
| Orthopedic Surgery | $583.97M+6.7% | $574.6M+5.6% | $556.22M+2.7% | $548.56M+2.4% | $547.37M+2.0% | |
| Net Sales by Geography | ||||||
| Americas (excluding the United States) | $129.55M+7.5% | $126.76M+4.7% | $123.39M+1.3% | $120.76M-1.3% | $120.53M-1.8% | |
| Asia Pacific | $206.97M+6.7% | $208.72M+7.2% | $199.3M+4.7% | $194.69M+0.1% | $194.01M-0.9% | |
| Europe, Middle East & Africa | $270.12M+9.9% | $264.65M+8.9% | $253.13M+5.2% | $249.97M+5.7% | $245.88M+6.4% | |
| United States | $763.88M+1.1% | $774.59M+3.5% | $771.65M+4.9% | $760.83M+5.3% | $755.58M+6.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does CONMED break its business down?
- CONMED (CNMD) reports net sales by product across 2 parts — General Surgery and Orthopedic Surgery. Each is extracted from the segment footnotes and tracked over time.
- Where does CONMED's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in CONMED's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
